Synthetic alpha-thrombin receptor peptides activate G protein-coupled signaling pathways but are unable to induce mitogenesis

V Vouret-Craviari, E Van Obberghen-Schilling, UB Rasmussen, A Pavirani, JP Lecocq and J Pouyssegur

Centre de Biochimie, C.N.R.S.-I.N.S.E.R.M., Nice, France.

alpha-Thrombin (thrombin) stimulates phospholipase C and modulates the activity of adenylate cyclase in a number of cell types via G protein- coupled receptors. It is also a potent growth factor, notably for a line of hamster fibroblasts (CCL39 cells). Recently, predicted amino acid sequences for human and hamster thrombin receptors have been reported that display a putative thrombin cleavage site in the N- terminal extracellular domain. Synthetic peptides corresponding to 14 residues carboxyl to the presumed thrombin cleavage site of the human receptor have been shown to activate platelets as well as the thrombin receptor expressed in Xenopus oocytes. In the present study we have examined the effects of synthetic peptides corresponding to the same region of the hamster receptor (S-42-L-55) and shorter peptides (2-7 residues) on signal transducing systems in CCL39 cells. Our results indicate that hamster receptor peptides of greater than or equal to 5 residues effectively stimulate phospholipase C in CCL39 cells via the thrombin receptor and induce rapid desensitization of the response. The same peptides also inhibit adenylate cyclase in a pertussis toxin- sensitive manner. Although the peptides are potent agonists of serotonin release in platelets, unlike thrombin, by themselves they are not mitogenic. However, they potentiate DNA synthesis in cooperation with growth factors possessing tyrosine kinase receptors. Hence, we conclude that the potent mitogenic action of thrombin cannot be accounted for solely by the activation of the cloned receptor. We postulate the existence of an additional receptor activated by thrombin, which is required for its full mitogenic potential.

Volume 3, Issue 1, pp. 95-102, 01/01/1992
Copyright © 1992 by The American Society for Cell Biology

This article has been cited by other articles:

				J. N. McLaughlin, L. Shen, M. Holinstat, J. D. Brooks, E. DiBenedetto, and H. E. Hamm Functional Selectivity of G Protein Signaling by Agonist Peptides and Thrombin for the Protease-activated Receptor-1 J. Biol. Chem., July 1, 2005; 280(26): 25048 - 25059. [Abstract] [Full Text] [PDF]

				A. Gasmi, C. Bourcier, Z. Aloui, N. Srairi, S. Marchetti, C. Gimond, S. R. Wedge, L. Hennequin, and J. Pouyssegur Complete Structure of an Increasing Capillary Permeability Protein (ICPP) Purified from Vipera lebetina Venom. ICPP IS ANGIOGENIC VIA VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING J. Biol. Chem., August 9, 2002; 277(33): 29992 - 29998. [Abstract] [Full Text] [PDF]

				S. R. Macfarlane, M. J. Seatter, T. Kanke, G. D. Hunter, and R. Plevin Proteinase-Activated Receptors Pharmacol. Rev., June 1, 2001; 53(2): 245 - 282. [Abstract] [Full Text] [PDF]

				M. R. D'Andrea, C. K. Derian, R. J. Santulli, and P. Andrade-Gordon Differential Expression of Protease-Activated Receptors-1 and -2 in Stromal Fibroblasts of Normal, Benign, and Malignant Human Tissues Am. J. Pathol., June 1, 2001; 158(6): 2031 - 2041. [Abstract] [Full Text] [PDF]

				J.-H. Lee, P. R. A. Johnson, M. Roth, N. H. Hunt, and J. L. Black ERK activation and mitogenesis in human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, May 1, 2001; 280(5): L1019 - L1029. [Abstract] [Full Text] [PDF]

				B. D. Blackhart, L. Ruslim-Litrus, C.-C. Lu, V. L. Alves, W. Teng, R. M. Scarborough, E. E. Reynolds, and D. Oksenberg Extracellular Mutations of Protease-Activated Receptor-1 Result in Differential Activation by Thrombin and Thrombin Receptor Agonist Peptide Mol. Pharmacol., April 13, 2001; 58(6): 1178 - 1187. [Abstract] [Full Text]

				J. Zain, Y.-Q. Huang, X. Feng, M. L. Nierodzik, J.-J. Li, and S. Karpatkin Concentration-dependent dual effect of thrombin on impaired growth/apoptosis or mitogenesis in tumor cells Blood, May 15, 2000; 95(10): 3133 - 3138. [Abstract] [Full Text] [PDF]

				M. L. Rand, W. Sangrar, M. A. Hancock, D. M. Taylor, S. M. Marcovina, M. A. Packham, and M. L. Koschinsky Apolipoprotein(a) Enhances Platelet Responses to the Thrombin Receptor–Activating Peptide SFLLRN Arterioscler. Thromb. Vasc. Biol., September 1, 1998; 18(9): 1393 - 1399. [Abstract] [Full Text] [PDF]

				L. Maulon, S. Guerin, J.-E. Ricci, D. FarahiFar, J.-P. Breittmayer, and P. Auberger T-Cell Receptor Signaling Pathway Exerts a Negative Control on Thrombin-Mediated Increase in [Ca2+]i and p38 MAPK Activation in Jurkat T Cells: Implication of the Tyrosine Kinase p56Lck Blood, June 1, 1998; 91(11): 4232 - 4241. [Abstract] [Full Text] [PDF]

				L. T. Nguyen, H. Lum, C. Tiruppathi, and A. B. Malik Site-specific thrombin receptor antibodies inhibit Ca2+ signaling and increased endothelial permeability Am J Physiol Cell Physiol, November 1, 1997; 273(5): C1756 - C1763. [Abstract] [Full Text] [PDF]

				J. Trejo, A. J. Connolly, and S. R. Coughlin The Cloned Thrombin Receptor Is Necessary and Sufficient for Activation of Mitogen-activated Protein Kinase and Mitogenesis in Mouse Lung Fibroblasts. LOSS OF RESPONSES IN FIBROBLASTS FROM RECEPTOR KNOCKOUT MICE J. Biol. Chem., August 30, 1996; 271(35): 21536 - 21541. [Abstract] [Full Text] [PDF]

				G. N. Rao and M. S. Runge Cyclic AMP Inhibition of Thrombin-induced Growth in Vascular Smooth Muscle Cells Correlates with Decreased JNK1 Activity and c-Jun Expression J. Biol. Chem., August 23, 1996; 271(34): 20805 - 20810. [Abstract] [Full Text] [PDF]

				V. B. Schini-Kerth, B. Fisslthaler, E. Van Obberghen-Schilling, and R. Busse Serotonin Stimulates the Expression of Thrombin Receptors in Cultured Vascular Smooth Muscle Cells : Role of Protein Kinase C and Protein Tyrosine Kinases Circulation, June 15, 1996; 93(12): 2170 - 2177. [Abstract] [Full Text]

				H. Ali, E. D. Tomhave, R. M. Richardson, B. Haribabu, and R. Snyderman Thrombin Primes Responsiveness of Selective Chemoattractant Receptors at a Site Distal to G Protein Activation J. Biol. Chem., February 9, 1996; 271(6): 3200 - 3206. [Abstract] [Full Text] [PDF]

				G. N. Rao, P. Delafontaine, and M. S. Runge Thrombin Stimulates Phosphorylation of Insulin-like Growth Factor-1 Receptor, Insulin Receptor Substrate-1, and Phospholipase C-[IMAGE]1 in Rat Aortic Smooth Muscle Cells J. Biol. Chem., November 17, 1995; 270(46): 27871 - 27875. [Abstract] [Full Text] [PDF]

				A. Sachinidis, M. Flesch, Y. Ko, K. Schror, M. Bohm, R. Dusing, and H. Vetter Thromboxane A2 and Vascular Smooth Muscle Cell Proliferation Hypertension, November 1, 1995; 26(5): 771 - 780. [Abstract] [Full Text]

				G. Fager Thrombin and Proliferation of Vascular Smooth Muscle Cells Circ. Res., October 1, 1995; 77(4): 645 - 650. [Full Text]

				R. M. Kramer, E. F. Roberts, P. A. Hyslop, B. G. Utterback, K. Y. Hui, and J. A. Jakubowski Differential Activation of Cytosolic Phospholipase A[IMAGE] (cPLA[IMAGE]) by Thrombin and Thrombin Receptor Agonist Peptide in Human Platelets J. Biol. Chem., June 16, 1995; 270(24): 14816 - 14823. [Abstract] [Full Text] [PDF]

				V.ér. Vouret-Craviari, D. Grall, J.-C. Chambard, U. B. Rasmussen, J. Pouysségur, and E. Van Obberghen-Schilling Post-translational and Activation-dependent Modifications of the G Protein-coupled Thrombin Receptor J. Biol. Chem., April 7, 1995; 270(14): 8367 - 8372. [Abstract] [Full Text] [PDF]

				V.ér. Vouret-Craviari, P. Auberger, J. Pouysségur, and E. Van Obberghen-Schilling Distinct Mechanisms Regulate 5-HT(2) and Thrombin Receptor Desensitization J. Biol. Chem., March 3, 1995; 270(9): 4813 - 4821. [Abstract] [Full Text] [PDF]